Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Urologic Oncology|January 23, 2024
The association of body mass index with tumor aggression among men undergoing radical prostatectomyJustin R Gregg, Resa Magill, Andrew M Fang, et al.
Clinical Colorectal Cancer|November 24, 2020
Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal CancerShailesh M Advani, Michael D Swartz, Jonathan Loree, et al.
BMC Public Health|May 31, 2011
Multi-center feasibility study evaluating recruitment, variability in risk factors and biomarkers for a diet and cancer cohort in IndiaRashmi Sinha, Carrie R Daniel, Niveditha Devasenapathy, et al.
Urology|May 10, 2025
GLP-1 Agonist Use Among Men With Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical TrialsAndrew Fang, Daniel E Frigo, Andrew Hahn, et al.
The Journal of Urology|February 9, 2026
Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort StudyTarek Lawen, Rebekka S Garcia, Matthew T Smith, et al.
CA: a Cancer Journal for Clinicians|February 24, 2023
Translating energy balance research from the bench to the clinic to the community: Parallel animal-human studies in cancerMiriam B Garcia, Keri L Schadler, Joya Chandra, et al.
Nutrients|January 10, 2026
Investigating Chronic Toxicity, Diet, Patient-Reported Outcomes and the Microbiome in Immunotherapy-Treated Metastatic Melanoma Survivors: A New FrontierMargaux Robert, Satabdi Saha, Nazli Dizman, et al.
JAMA Dermatology|August 30, 2023
Gut Microbiome in Patients With Early-Stage and Late-Stage MelanomaRussell G Witt, Samuel H Cass, Tiffaney Tran, et al.
Biomarker Research|November 10, 2024
Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillanceJustin R Gregg, Lisa Newcomb, Ranran Wu, et al.
Ebiomedicine|December 1, 2023
Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trialXiaotao Zhang, Ehsan Irajizad, Kristi L Hoffman, et al.
Pageof 9